Median Technologies

Medical imaging technology company providing AI-powered imaging solutions and clinical trial services for oncology drug development and early cancer diagnosis.

Location
Sophia Antipolis, France
Founded
2002
Investors
1
Categories
healthcare-technology, medical-imaging, ai, oncology, diagnostics

Notes

Median Technologies is a healthcare technology company specializing in AI-powered medical imaging solutions. The company provides services to pharmaceutical companies conducting oncology clinical trials and is developing AI-based diagnostic products for early cancer detection.

Listed on Euronext Growth Paris, Median has established itself as a leader in imaging analysis for clinical trials, particularly in oncology, while also advancing its iBiopsy® platform for early cancer diagnosis using AI and radiomics.

Team

Additional Research Findings

  • Founded in 2002
  • Headquarters in Sophia Antipolis, France
  • Listed on Euronext Growth Paris (ALMDT)
  • Portfolio company of Abingworth
  • iBiopsy® AI platform for cancer diagnosis
  • Clinical trial imaging services for pharma
  • Focus on oncology imaging
  • Radiomics and AI expertise

Sources

Investors

NameLocationTypeStagesPortfolio
AbingworthLondon, UK / Boston, USAbiotech-focused
seedseries-a+3
34